| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/19/2000 | EP0666845B1 Method for purifying beta-carotene |
| 07/19/2000 | EP0664291B1 Pyrimidine compound |
| 07/19/2000 | EP0661966B1 Ulcer prevention and treatment composition and method |
| 07/19/2000 | EP0641355B1 Use of sulphamate derivatives as steroid sulphatase inhibitors |
| 07/19/2000 | EP0573565B1 Opiate receptor antagonist modulates hyperkinetic movement disorder |
| 07/19/2000 | EP0514452B2 Use of insulin sensitizing agents to treat hypertension |
| 07/19/2000 | EP0482208B1 Pyridazinone derivative |
| 07/19/2000 | CN1260802A 20-aralkyl-5 'alpha'-pregnane derivatives |
| 07/19/2000 | CN1260801A Novel glycosylated ginkgolide derivatives, their applicated as medicines and pharmaceutical compositions |
| 07/19/2000 | CN1260798A Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha 1-blocking action |
| 07/19/2000 | CN1260797A 3-substituted 3,4-dihydro-thieno (2,3-d) pyrimidine derivatives and preparation and use of same |
| 07/19/2000 | CN1260796A Alkaloid halide salts of swainsonine and methods of use |
| 07/19/2000 | CN1260795A Quaternary ammonium compounds as tachykinin antagenists |
| 07/19/2000 | CN1260794A 5-aryl-3-(8-azabicyclo (3.2.2) oct-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives as -5HT4 receptor ligands |
| 07/19/2000 | CN1260793A 4-haloalkyl-3-heterocyclyl pyridines and 4-haloalkyl-5-heterocyclylpyridines, method for producing same, composition containing same and use thereof |
| 07/19/2000 | CN1260792A Treatment of central nervous system disorders with selective estrogen receptor modulators |
| 07/19/2000 | CN1260791A 3-benzylpiperidine |
| 07/19/2000 | CN1260789A Heterocyclic compounds, method for preparing and medicine compositions containing same |
| 07/19/2000 | CN1260784A Quinoline derivatives as PDEIV and INF inhibitors |
| 07/19/2000 | CN1260782A Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors |
| 07/19/2000 | CN1260781A Indole derivatives having combined 5HT1A, 5HT1B and 5HT1D receptor antagoinist activity |
| 07/19/2000 | CN1260780A Ace-inhibitor nitric salts |
| 07/19/2000 | CN1260778A Prostaglandin pharmaceutical compositions |
| 07/19/2000 | CN1260774A Method for producing medicines containing HMG-CoA-reductase inhibitors |
| 07/19/2000 | CN1260725A Conjugate composing folic acid antagonist and carrier |
| 07/19/2000 | CN1260719A Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 07/19/2000 | CN1260718A Antithelmintic compositions |
| 07/19/2000 | CN1260717A Use of 1-ar (alk)yl-imidazoline-2-one for treating anxietyand stress conditions |
| 07/19/2000 | CN1260716A Treatment of diabetes with thiazolidinedione and metformin |
| 07/19/2000 | CN1260715A Treatment of diabetes with rosiglitazone and insulin |
| 07/19/2000 | CN1260714A Controlled release pharmaceutical preparation with ACE inhibitor as active agent |
| 07/19/2000 | CN1260713A Proliposome powders for inhalation stabilised by tocopherol |
| 07/19/2000 | CN1260706A Personal care composition comprising silicone-containing adhesive copolymer |
| 07/19/2000 | CN1260703A Drug delivery device and method for treating viral and microbial infections and wasting syndromes |
| 07/19/2000 | CN1260347A Chlorophyll alpha degraded product metal complex, its preparation method and medicament for anti-gastric ulcer |
| 07/19/2000 | CN1260345A Hydrazide compound, its preparing method and medicine compositions thereof |
| 07/19/2000 | CN1260197A Bone-calcium liquid protein and its preparation method |
| 07/19/2000 | CN1260189A Application of radix scutellariae stem and leaf to pharmaceutical industry |
| 07/19/2000 | CN1260185A Dongchuangjin (wiping out frostbite) and its preparation technology |
| 07/19/2000 | CN1260180A Application of lung surface active matter to pharmaceutical industry |
| 07/19/2000 | CN1260179A Nucleic acid oral powder and its production method |
| 07/19/2000 | CN1260177A Oral liquor of cytidine disphosphate choline and its preparation method |
| 07/19/2000 | CN1260176A 'Pijiting' preparation for treating dermatosis and its preparation method |
| 07/19/2000 | CN1260175A Compound aminoacyl damobin calcium tablet |
| 07/19/2000 | CN1260174A Liquid preparation containing norfloxacin and metronidazole |
| 07/19/2000 | CN1260173A Immuno inhibitort |
| 07/19/2000 | CN1260172A Dextro-betoprofen preparation |
| 07/19/2000 | CN1260171A Recombined alpha-type interferon freeze-drying protective agent |
| 07/19/2000 | CN1260132A Water-soluble crustaceous amine-contained food |
| 07/19/2000 | CN1260117A 烟水两用消毒剂 Dual smoke water disinfectant |
| 07/19/2000 | CN1054606C Process for preparing anti-virus chemical compound-Babaosu |
| 07/19/2000 | CN1054603C Tri-substituted phenyl derivatives and medicinal composition containing same |
| 07/19/2000 | CN1054602C Meta-nisoldipine and synthesizing method thereof |
| 07/19/2000 | CN1054601C Fluoride like vitamine D3, its preparation method and use, and medicinal composition containing same |
| 07/19/2000 | CN1054599C Hydroxamic acid derivatives and preparation method and use |
| 07/19/2000 | CN1054598C Pharmacalogically active hydrazine derivatives and process for preparation thereof |
| 07/19/2000 | CN1054538C Liniment for treating vitiligo and its preparing method |
| 07/19/2000 | CN1054537C Medicine for treating centripetalis obesity |
| 07/19/2000 | CN1054512C Physiological multi-salt solution |
| 07/19/2000 | CN1054510C Stable solution of rebeccamycin analog and preparation thereof |
| 07/19/2000 | CN1054509C Synergistic interplay of lymphokines and dsRNAs |
| 07/19/2000 | CN1054508C Method for preparing pharmaceutical composition |
| 07/19/2000 | CN1054507C Preparation method for medicinal composition for treatment of vaginal infections |
| 07/19/2000 | CN1054506C Pharmaceutical composition use |
| 07/19/2000 | CN1054504C Tooth-cleaning unit |
| 07/18/2000 | USRE36784 Chemoprotective isothiocyanates |
| 07/18/2000 | US6090997 Method and composition for preventing surgical adhesions and tissue damage employing fluorinated polymers |
| 07/18/2000 | US6090981 Antiarrhythmics. |
| 07/18/2000 | US6090955 Liposome-encapsulated taxol, its preparation and its use |
| 07/18/2000 | US6090953 Pyronin antibacterials, process and novel intermediates thereto |
| 07/18/2000 | US6090948 Inhibitors of farnesyl-protein transferase |
| 07/18/2000 | US6090945 Tetrahydro-beta-carbolines |
| 07/18/2000 | US6090944 Alkanoic acid derivatives as αv integrin receptor antagonists |
| 07/18/2000 | US6090942 Process and intermediates for a β3 -adrenergic receptor agonist |
| 07/18/2000 | US6090941 Pharmaceutically active benzoquinazoline compounds |
| 07/18/2000 | US6090932 Method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 07/18/2000 | US6090918 Polypeptide associated with the inhibition of prostaglandin biosynthesis and treating inflammation |
| 07/18/2000 | US6090856 Comprises tramadol or a salt thereof as an active ingredient. |
| 07/18/2000 | US6090854 Aryloxyanilides and related compounds |
| 07/18/2000 | US6090852 Matrix metalloprotease inhibitor |
| 07/18/2000 | US6090851 Use of an NADPH-oxidase inhibitor in the treatment of reperfusion injury |
| 07/18/2000 | US6090849 Carnitine supplemented diet to prevent sudden death syndrome in breeder type poultry |
| 07/18/2000 | US6090848 Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans |
| 07/18/2000 | US6090847 EP2 -receptor agonists as neuroprotective agents for the eye |
| 07/18/2000 | US6090846 Administering s-ethyl-n-((4-trifluoromethyl)phenyl)isothiourea |
| 07/18/2000 | US6090845 Hypotensive agent; vision defects |
| 07/18/2000 | US6090844 Pharmaceutical injection solution containing taxol |
| 07/18/2000 | US6090843 Benzothiophenes compounds which have useful pharmaceutical activity |
| 07/18/2000 | US6090842 Reduces concentration of oxygen in cells |
| 07/18/2000 | US6090840 Peptidyl compounds having MMP and TNF inhibitory activity |
| 07/18/2000 | US6090838 Methods and compositions for inhibition of adaptor protein/tyrosine kinase interactions |
| 07/18/2000 | US6090837 Substituted hydrochromenopyrroles |
| 07/18/2000 | US6090836 Benzisoxazole-derived antidiabetic compounds |
| 07/18/2000 | US6090833 Polycyclic dihydrothiazoles, their preparation, and use as pharmaceuticals |
| 07/18/2000 | US6090830 Controlled release compositions and methods for the treatment of hyperlipidemia |
| 07/18/2000 | US6090829 Method for treating excessive aggression |
| 07/18/2000 | US6090827 Pharmaceutical formulation of omeprazole |
| 07/18/2000 | US6090826 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 07/18/2000 | US6090825 Oxazole derivatives as antagonists of alpha 1C andrenergic receptors |
| 07/18/2000 | US6090824 Therapeutic neurokinin receptor antagonist compounds |